...
首页> 外文期刊>Journal of neurosurgical anesthesiology >Remifentanil Requirement for Inhibiting Responses to Tracheal Intubation and Skin Incision Is Reduced in Patients With Parkinson's Disease Undergoing Deep Brain Stimulator Implantation
【24h】

Remifentanil Requirement for Inhibiting Responses to Tracheal Intubation and Skin Incision Is Reduced in Patients With Parkinson's Disease Undergoing Deep Brain Stimulator Implantation

机译:接受深度脑刺激植入术的帕金森氏病患者抑制瑞米芬太尼抑制气管插管和皮肤切开反应的要求

获取原文
获取原文并翻译 | 示例

摘要

Background: Parkinson's disease (PD) is a common neurodegenerative disease affecting the quality of life in the elderly. We speculated that PD patients might have abnormal pharmacodynamics due to the degenerative neural system, and the present study was performed to investigate the pharmacodynamics of remifentanil in PD patients.
机译:背景:帕金森氏病(PD)是一种常见的神经退行性疾病,会影响老年人的生活质量。我们推测PD患者可能由于神经系统的退行性而具有异常的药效学,因此本研究旨在研究瑞芬太尼在PD患者中的药效学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号